Back to Home » January 2021 News » Nanoform's Clinical Study Indicates Positive Interim Results |
Nanoform's Clinical Study Indicates Positive Interim Results |
January 22, 2021
HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful. Nanoform has...
Source URL: https://www.prnewswire.com:443/news-releases/nanoforms-clinical-study-indicates-positive-interim-results-301213028.html
|
|
|
|